Quaternized Amines Block Sodium Channels for Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pain therapies often have limited efficacy and undesirable side effects, and many patients with acute or chronic pain disorders do not respond well to available treatments, highlighting a need for more effective and safer analgesics that target sodium channels.
Innovation Solution
Development of substituted pyridine and pyrimidine compounds that act as blockers of sodium (Na+) channels, which can be administered to treat various disorders responsive to sodium channel blockade, including pain, epilepsy, and cardiac arrhythmia, by modulating sodium channel function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current pain therapies are used, then pain relief is provided, but side effects increase and efficacy is limited
Solution Approach 1:
The patent applies parameter changes by developing novel chemical compounds with modified molecular structures (quaternized amine groups attached to specific pharmacophores) to achieve selective sodium channel blockade. This structural parameter change enables differentiated binding affinity across sodium channel isoforms, improving therapeutic efficacy while reducing off-target side effects compared to conventional analgesics
Solution Approach 2:
The invention segments the sodium channel blockade function by designing compounds that selectively target specific sodium channel isoforms (e.g., Nav1.7, Nav1.8, Nav1.9) rather than blocking all sodium channels non-selectively. This segmentation approach explains the improved efficacy-safety profile by affecting only the pathological channels involved in pain transmission while sparing channels critical for normal physiological functions
2Reliability
If conventional analgesics are administered, then pain treatment is attempted, but many patients do not respond adequately
Solution Approach 1:
The patent applies local quality by designing compounds with specific molecular features (quaternized amine groups at defined positions on pharmacophoric cores) that create localized high-affinity interactions with particular sodium channel isoforms. This localized molecular design enables selective modulation of pain-related sodium channels while maintaining compatibility across diverse patient populations with varying pain pathologies
Data Source
AI summary
The present disclosure provides substituted pyridine and pyrimidine compounds of Formula (I): A1-X-A2-Z-R1 (I) and the pharmaceutically acceptable salts, solvates and prodrugs thereof, wherein A, X, A, Z, and R are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.